Director, Hemophilia, Product Communications

Location:  San Rafael, California Category: Corporate


Who We Are

For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were founded to make a big difference in small patient populations. Now we seek to make an even greater impact by applying the same science-driven, patient-forward approach that propelled our last 25 years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The end goal has always been better lives and now we can reach more.

And the more people we reach, the more our impact can grow. We transform lives through genetic discovery.

Our Culture

Our desire to make a positive impact on our patients extends to our employees and BioMarin is committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. We seek to provide an open, flexible, and friendly work environment to empower people and to provide them with the ability to develop their long-term careers. Ultimately, we want to be an organization where people enjoy coming to work and take pride in our efforts to help patients.

By providing a foundation for all operations company wide, BioMarin’s General and Administrative teams support our mission of providing first and best in class therapeutics to patients who live with rare diseases. Our teams include groups such as finance, legal, human resources, corporate compliance and ethics, and information technology. Come join our team and make a meaningful impact on patients’ lives.

We are seeking an experienced and enthusiastic leader to drive the media communications strategy for the ongoing launch of our hemophilia A gene therapy, which is on the market in Europe and under regulatory review in the United States. This individual, who will be part of the growing Corporate Communications team, will be responsible for the development of an integrated communications strategy that underscores the scientific innovation and significant value of our therapy to patients and healthcare systems. This individual will be responsible for elevating BioMarin’s profile in the hematology community and enhancing the company’s reputation within this key stakeholder group and beyond.

The Director, Hemophilia, Product Communications will help the company articulate its vision across external and internal audiences, raising awareness of the unmet medical need in hemophilia and the company’s track record of innovation in developing transformative therapies based on genetic discovery.

Working closely with leaders across BioMarin, including the Commercial brand team, Investor Relations, Government Affairs and Global Patient Affairs, this role reports to the Executive Director, Media Relations & Product Communications, as part of the Corporate Communications team.

Roles and responsibilities

  • Develop and execute a communications strategy that establishes BioMarin as the leader in treating patients with severe hemophilia A, emphasizing the value of the company’s gene therapy and the scientific innovation of the company
  • Enhance BioMarin’s reputation as a trusted partner in the hemophilia community, working closely and cross-functionally with the Commercial and Global Patient Affairs organizations
  • Enhance the reputation of company scientists and executives as thought leaders, identifying appropriate speaking opportunities and amplifying those engagements internally/externally
  • Represent the Corporate Communications team on cross-functional work streams and project teams, clearly identifying media opportunities and challenges
  • Create insight driven engagement and communications plans, in partnership with the company’s PR agency partners, to develop best-in-industry content that supports the needs of the business
  • Anticipate and lead response to media inquiries related to hemophilia
  • Collaborate closely with R&D colleagues to grow awareness and understanding of BioMarin’s scientific expertise and ongoing clinical programs to expand into new indications
  • Develop press releases related to the company’s hemophilia product and lead internal stakeholder/compliance review
  • Partner with Corporate Communications colleagues on internal communications project/events and social media to create content that is compelling and relevant
  • Serve as trusted advisor within the organization


  • At least 10-15 years in public relations, with experience leading product communications in the biopharmaceutical industry, preferably in-house
  • Excellent writer and natural storyteller with superior verbal communications skills
  • Ability to build consensus and influence across the organization and work as part of a growing team
  • Experience driving successful media relations strategies, including acting as a company spokesperson
  • Experience with drug product approvals and a deep understanding of the BLA/NDA and sBLA/sNDA process
  • Experience in identification of issues and proactive issues/crisis management
  • Demonstrated knowledge of regulations governing communications for a publicly traded biopharmaceutical company and strong understanding of the healthcare policy environm
  • BS/BA in science, communications, liberal arts and advanced degree in communications, public relations, journalism or business preferred

PLEASE NOTE: Absent a Medical or Religious reason that prohibits vaccinations, all our incoming employees must be vaccinated for COVID-19.

We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.